Integrated bioinformatics analysis of miRNA expression in osteosarcoma
Source abstract
Abstract
The expression of miRNA influencing the pathogenesis of OS have been reported previously, however, different samples selection and sequencing platforms made obvious differences in miRNA expression analysis. We aim to identify reliable prognostic and treatment biomarkers for OS by systematic analysis of miRNAs expression data sets from biased data set. Seven miRNA data sets were selected from corresponding articles. Collectively, two miRNAs, hsa-miR-19-3p and hsa-miR106b-3p, and transcription factor SIX3 were identified and may be reliable markers for prognostic and treatment of osteosarcoma.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: MicroRNA in disease regulation · Cancer-related molecular mechanisms research · Circular RNAs in diseases
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
West China School of Medicine, Sichuan University, Chengdu, China;
Department of Medical Oncology, The First Affiliated Hospital of Gannan Medical College, Ganzhou, China;
Department of Orthopaedics, West China Hospital, Sichuan University, Chengdu, China
References (30)
Show source-provided references
1. 10.1074/jbc.M40570320010.1074/jbc.M405703200 ↗
2. 10.1007/s00432-013-1469-210.1007/s00432-013-1469-2 ↗
3. 10.1073/pnas.030732310110.1073/pnas.0307323101 ↗
4. Laflamme C · Cancer Res · 2003 · 63 · 449
5. Li D · Int J Clin Exp Pathol · 2014 · 7 · 7672
6. 10.1186/gb-2003-4-5-p310.1186/gb-2003-4-5-p3 ↗
7. 10.1101/gad.118440410.1101/gad.1184404 ↗
8. 10.1158/1535-7163.MCT-11-009610.1158/1535-7163.MCT-11-0096 ↗
9. 10.1093/nar/gkq14910.1093/nar/gkq149 ↗
10. 10.1093/nar/gkm95210.1093/nar/gkm952 ↗
11. Hu H · Oncol Lett · 2012 · 4 · 103710.3892/ol.2012.866 ↗
12. 10.1158/0008-5472.CAN-05-114610.1158/0008-5472.CAN-05-1146 ↗
13. 10.1158/0008-5472.CAN-11-266310.1158/0008-5472.CAN-11-2663 ↗
14. 10.1093/nar/gkq102710.1093/nar/gkq1027 ↗
15. 10.1158/0008-5472.CAN-03-382910.1158/0008-5472.CAN-03-3829 ↗
16. 10.1016/j.cell.2004.12.03510.1016/j.cell.2004.12.035 ↗
17. 10.7314/APJCP.2013.14.12.727110.7314/APJCP.2013.14.12.7271 ↗
18. 10.1016/j.cancergen.2010.12.01210.1016/j.cancergen.2010.12.012 ↗
19. 10.1371/journal.pone.007181610.1371/journal.pone.0071816 ↗
20. 10.1371/journal.pone.004808610.1371/journal.pone.0048086 ↗
21. 10.1101/gad.186140910.1101/gad.1861409 ↗
22. 10.1007/978-1-4419-0284-9_110.1007/978-1-4419-0284-9_1 ↗
23. 10.1158/0008-5472.CAN-10-090910.1158/0008-5472.CAN-10-0909 ↗
24. 10.1158/0008-5472.CAN-03-372010.1158/0008-5472.CAN-03-3720 ↗
25. 10.4161/cc.7.11.597710.4161/cc.7.11.5977 ↗
26. 10.2174/13892010778301839010.2174/138920107783018390 ↗
27. 10.4161/cbt.8.2.738510.4161/cbt.8.2.7385 ↗
28. 10.1016/j.bone.2011.10.01210.1016/j.bone.2011.10.012 ↗
29. 10.1016/j.cell.2008.02.01910.1016/j.cell.2008.02.019 ↗
30. 10.1371/journal.pone.008357110.1371/journal.pone.0083571 ↗